failure of ppi therapy -...
TRANSCRIPT
Joel E. Richter, MD, MACG
Intractable GERD: How to
ACG/FGS Annual Spring Symposium
Intractable GERD: How to Diagnose and Manage in 2014
Joel E Richter, MD, FACP, MACGHugh Culverhouse Chair and Director
Division of Digestive Diseases and NutritionDivision of Digestive Diseases and NutritionJoy McCann Culverhouse Center for Swallowing
DisordersUniversity of South Florida
Tampa, Florida
Failure of PPI Therapy• 10 - 40% of GERD patients fail to respond symptomatically
to standard once daily dose of PPIsFass R. Aliment Pharmacol Ther 2005
• Over 7 years (1997-2004), Manitoba province had 50%increase in use of BID PPIs (9.7% to 15.2%)Targownik LE. Am J Gastroenterol 2007Targownik LE. Am J Gastroenterol 2007
• Only 58% of GERD patients receiving PPIs report a highlevel of satisfaction with their therapyBytzer P. Clinical Gastroenterol and Hepatol 2009
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
1
Joel E. Richter, MD, MACG
Is There a Clinical or pH Profile for PPI Non-Responders?
• 100 patient: 43 responders 57 non-responders100 patient: 43 responders, 57 non responders• Clinical predictors:
BMI<25 kg/m2 Normal endoscopyIBS or functional dyspepsia
• No 24 hr pH-impedance parameters off PPIs• No 24 hr pH-impedance parameters off PPIswere predictive of response to PPIs
Zerbid F et al. Gut 2012
Failure to Respond to Once a Day PPI
• What to do next??• What to do next??Check complianceDose appropriatelySwitch PPIIncrease to BID PPI (up to 25% improve)Increase to BID PPI (up to 25% improve)
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
2
Joel E. Richter, MD, MACG
Sub-Optimal Proton Pump Inhibitor Dosing
100 ptsReferred by
PCPs46% dosedoptimally
Gunaratnam NT, et al. Alimentary Pharmacol Ther 2006
Failure to Respond to Once a Day PPI
• What to do next??• What to do next??Check complianceDose appropriatelySwitch PPIIncrease to BID PPI (up to 25% improve)Increase to BID PPI (up to 25% improve)
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
3
Joel E. Richter, MD, MACG
Failure to Respond to Once Daily PPIs:Switch PPI or Double Dose?
• Multicenter randomized double blind, double dummy trial• 328 pts with persistent heartburn on lansoprazole 30 mg• Randomly assigned to esomeprazole 40 mg
lansoprazole 30 mg BID• Both equally effective for:
- heartburn free days: 55% eso vs 58% lansoprazole- symptom score improvement for heartburn acidsymptom score improvement for heartburn, acid
regurgitation and epigastric pain-rescue antacid use
Fass R et al Clin Gastroenterol and Hepatology 2006
Persistent Heartburn Symptoms
Switch or Double Dose PPIs?None Mild Moderate Severe
100
Patie
nts (
%) 70
605040302010
8090
Lansoprazole30 mg twice daily
(n=44)
Esomeprazole40 mg once daily
(n=138)
Lansoprazole30 mg twice daily
(n=144)
Esomeprazole40 mg once daily
(n=138)
Week 4P=.25
Week 8P=.35
100
Fass R, et al. Clin Gastroenterol Hepatol. 2006;4:50-56.
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
4
Joel E. Richter, MD, MACG
GERD SymptomsPresence of esophagitis is unknown
Initial Treatment and Diagnostic Approach
Single dose PPI
Failure to improve
• Dose appropriately• Switch to newer PPI• BID PPI
Failure to improve –Refractory GERD or
Refractory Symptoms?
UGI Findings in Refractory GERD
PPI failures No TreatmentN=105 N=91
N l 54% 41%• Normal 54% p=.04 41%• Esophagitis 7% p<.001 31%
LA A/B 7% 29%LA C/D 0% 2%
• Barretts 4% 3%• Eosinophilic E 1% 0%• Ulcer Disease 1% 4%• Cancer 0% 1%
Poh CH et al GIE 2010
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
5
Joel E. Richter, MD, MACG
Failure to improve –Refractory GERD
Initial Treatment and Diagnostic Approach
Upper Endoscopy
Esophagitis—10% Non-esophagitis—90%
1. Pill esophagitis
2. Skin disease with esophagitisp g
3. Hypersecretor – ZE syndrome
4. CYP2C19 Genotype differences
5. Eosinophilic esophagitis
Fosamax Pill Esophagitis
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
6
Joel E. Richter, MD, MACG
PILL INDUCED ESOPHAGEAL INJURY
• 92 patients in 5 years—6% EGDs59 women, mean age 59, 25-87
• Common symptoms:odynophagia 75% chest pain 60% heartburn 55%vomiting 58% dysphagia 33% hematemesis 15%
• Causative pills:NSAIDs/ASA 41% tetracyclines 22%KCL tablets 10% alendronates 9%Other 16%--ascorbic acid, quinidine, antibiotics
S Abid et al Endscopy 2005
Lichen planus
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
7
Joel E. Richter, MD, MACG
Eosinophilic EsophagitisDemographics and Presenting Symptoms
• Presenting symptoms:• Presenting symptoms:Dysphagia: >90% Food impaction: 50%Heartburn: 33% Chest pain/ vomiting: 20%Most carry a diagnosis of GERD
Potter JW GIE 2004, Desai TK GIE 2005, Remedios M GIE 2005
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
8
Joel E. Richter, MD, MACG
Prevalence of Eosinophilic Esophagitis in Patients with Dysphagia
A Prospective Study
• 376 patients with dysphagia undergoing endoscopy
• Findings:Total # Biopsied #EoE(%)
Normal 180 102 10(10%)Reflux esophagitis 84 48 7(14%)Schatzki ring 28 18 1( 5%)Stricture 17 8 4(50%)Suggestive EoE 21 21 8(38%)Other* 46 30 3(10%)
*achalasia, Barretts, ulcer, cancer
Prasad G Am J Gastro 2007
Overall rate: 14.5%
Failure to improve –Refractory GERD
Upper Endoscopy
Failure to improve –Refractory GERD
Initial Treatment and Diagnostic Approach
pp py
Esophagitis—10% Non-esophagitis—90%
1. Pill esophagitis
2. Skin disease with esophagitis
3. Hypersecretor – ZE syndrome
•Persistent acid reflux•Weak or non-acid GER•Sensitive esophagus•Missed GERyp y
4. Genotype differences
5. Eosinophilic esophagitis
•Wrong diagnosis•Achalasia•Gastroparesis•“Functional” heartburn
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
9
Joel E. Richter, MD, MACG
PPI Resistant Patients—What is the Clinical Question??
• Insufficent PPIs to control acid reflux??• Insufficent PPIs to control acid reflux??
4
30
ROLE OF PH MONITORING IN SYMPTOMATIC PATIENTS ON THERAPY
Dis
tal T
otal
Tim
e pH
<
10
15
20
25
Upper limit of normal
%
0
5
QDATYPICAL GERD
(n = 145) )
BIDQD BIDTYPICAL GERD
(n = 175) )
Samer and Vaezi, A m J Gastroenterol 2005
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
10
Joel E. Richter, MD, MACG
Symptom Analysis
SI>50%
SSI>10%
Calculation of the SAP
Reflux event+
Sym
ptom
-+
+ -
S-R+
S+R+ S+R-
S-R-
Fisher’s exact testtwo-tailed
Weusten BLAM et al. Gastroenterology 1994
= [1 – p value] X 100%SAP
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
11
Joel E. Richter, MD, MACG
Concordance Concordance of Symptom of Symptom Assessments with Omeprazole TestAssessments with Omeprazole Test
Taghavi SA et al. Gut 2005
Hypersensitive Esophagus (SI+/SI-)Response to Omeprazole 20 mg BID for 4 Weeks
All had normal % total time pH<4
Watson, et al. Gut 1997
Reflux symptom score Days per week of reflux symptoms
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
12
Joel E. Richter, MD, MACG
Citalopram (Celexa) 20 mg for 6 months in Treatment of Hypersensitive Esophagus
Viazis N et al. Am J Gastroenterology 2012
PPI Resistant Patients—What is the Clinical Question??
• Insufficent PPIs to control acid reflux??• Insufficent PPIs to control acid reflux??• Uncontrolled Weak or Non-Acid Reflux??
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
13
Joel E. Richter, MD, MACG
Impedance pH Monitoring
• Resistance to the flow of alternating currentof alternating current
AirEsophageal LiningSalivaan
ce
SalivaFoodRefluxate
Impe
d
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
14
Joel E. Richter, MD, MACG
Number of Reflux Episodes Off and On PPIs
Hemmink GJM, et al Am J Gastro 2008
Symptom Episodes Off and On PPIs
Hemmink GJM, et al Am J Gastro 2008
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
15
Joel E. Richter, MD, MACG
Etiology of Refractory GERDPersistent Acid Reflux 1% - 15%
Refractory “GERD”
Symptoms onPPIs
Non-Acid GERD Not GERD
50% 60%GERD
30% - 40%
50% - 60%
GER Controlled on PPIs
Another DiagnosisMainie et al Gut 2006Zerbid et al Am J Gastro 2006
Effects of Baclofen 40 mg on Esophageal Function
Transient LES relaxations % Time pH < 4
Zhang Q, et al. Gut 2002
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
16
Joel E. Richter, MD, MACG
Impedance Not Predictor of Response
100%
Predictors of Surgical Outcome: moderate to large hiatal hernia (>4cm);% time ph < 4 greater than 10% and HB/regurg at baseline
30%
40%
50%
60%
70%
80%
90%
Pro
bab
ility
nse
to F
undo
plic
atio
n
Francis and Vaezi, Laryngoscope 2011
+ HeartburnAcid Reflux > 12%
- HeartburnAcid Reflux > 12%
- HeartburnAcid Reflux Š 12%
+ HeartburnAcid Reflux Š 12%
0%
10%
20%
30%
Res
pon
-HB/Regurg +HB/Regurg -HB/Regurg +HB/Regurg-pH -pH +pH +pH
PPI Resistant Patients—What is the Clinical Question??
• Insufficent PPIs to control acid reflux??U t ll d N A id R fl ??• Uncontrolled Non-Acid Reflux??
• Patient does not have acid reflux??Look for other diagnosesRefer patients with extraesophageal complaintsRefer patients with extraesophageal complaints
back to ENT, lung, and cardiac specialistsStop unnecessary and expensive PPIs
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
17
Joel E. Richter, MD, MACG
Catheter-Free pH Monitoring
• Capsule device with pH sensor• Attachment to distal esophageal mucosa• Radiotransmission of pH data
Catheter-Free pH Monitoring
Transoral during endoscopyTransoral without endoscopyTransnasal after manometry
Placement methods
• Capsule device with pH sensor• Attachment to distal esophageal mucosa• Radiotransmission of pH data
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
18
Joel E. Richter, MD, MACG
Catheter-Free pH Monitoring
Transoral during endoscopyTransoral without endoscopyTransnasal after manometry
Placement methods
• Capsule device with pH sensor• Attachment to distal esophageal mucosa• Radiotransmission of pH data
Extended Recording Time Identifies More Extended Recording Time Identifies More Abnormal GERAbnormal GER
Prakash C et al Clin Gastro Hepatology 2005
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
19
Joel E. Richter, MD, MACG
Normal Bravo pH Test
It’s Like a Baseball Game
• Strike 1atypical symptoms normal endoscopyatypical symptoms, normal endoscopy
• Strike 2no response to BID-QID PPIs for months/yrs
St ik 3• Strike 3normal 24-48 hrs ph test off PPIs for 2 weeks
YOU’RE OUT—NO GERD
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
20
Joel E. Richter, MD, MACG
PPIs and Esophageal pH Testing
High Probability GERD• Classic Symptoms• Suggestive EGD
Low Probability GERD• Atypical Symptoms• Extraesophageal Sx Suggest e G
• Hx of Previous PPI Response
PPBID PPIs
Improved No or Partial Response
•R/O Non-acid Reflux•Diagnosis Made
p g• Normal endoscopy• Previous Failure on PPI
Off PPI
pH TestingBravo Capsule•T l H
Impedance pH on BID PPIsPPIs
↑Non-Acid ↑Acid Normal•Baclofen•? Surgery
•Switch PPIs•? Surgery
•GER or no GER??
•Transnasal pH•Impedance pH
Normal Abnormal pH
•Stop PPIs
•BID PPI Trial
PPI Use after Negative Reflux Tests• Chart review and telephone survey• 90 patients with negative Bravo/impedance• 90 patients with negative Bravo/impedance
pH off PPIs
• 38 (42%) still using PPIs 2 yrs later17 patients recalled being told to stop PPIs15 patient’s chart documented instruction15 patient s chart documented instruction13 on BID PPIs
• No predictors of continued PPI useGawron AJ et al. Clinical GI and Hepatology 2012
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
21
Joel E. Richter, MD, MACG
Rebound Dyspepsia SymptomsPantoprazole vs Placebo
Niklasson, et al. Am J Gastroenterol 2010
Pantoprazole Placebo
WRONG DIAGNOSIS
• Achalasiaesophagus minimally dilateddiagnosis made by manometry
• Delayed gastric emptyingusually postprandial pain and regurgitation are major symptoms-not heartburn
• RuminationRumination
• Aerophagia
• “Functional “ heartburn—up to 58%
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
22
Joel E. Richter, MD, MACG
Increased Prandial Air Swallowing—Potential Cause of Refractory GERD
Bravi I et al. Clin Gastro and Hepatology 2013
Failure to improve –Refractory GERD
Upper Endoscopy
Failure to improve –Refractory GERD
Initial Treatment and Diagnostic Approach
pp py
Esophagitis—10% Non-esophagitis—90%
1. Pill esophagitis
2. Skin disease with esophagitis
3. Hypersecretor – ZE syndrome •Persistent acid reflux
Bravo 48 hr pHLow probability
Impedance pHHigh probability
yp y
4. Genotype differences
5. Eosinophilic esophagitis
•Weak or non-acid GER•Sensitive esophagus•Missed GER•Wrong diagnosis
•Achalasia•Gastroparesis•“Functional” heartburn
ACG/FGS Spring Symposium - Bonita Springs, FL Copyright 2014 American College of Gastroenterology
23